GNH USA

Europe — EMA

Olmesartan Medoxomilo Refta Ratiopharm

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomilo Refta Ratiopharm, is an angiotensin II receptor blocker presented as a tablet for oral use.

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomilo Refta Ratiopharm, is an angiotensin II receptor blocker presented as a tablet for oral use. It is indicated for the management of hypertension in adult patients. GNH USA supplies Olmesartan Medoxomilo Refta Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomilo Refta Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan medoxil is used to treat high blood pressure by targeting the renin‑angiotensin system.

- Hypertension: Lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Diabetic nephropathy: Helps slow progression of kidney damage associated with diabetes. - Heart failure prevention: Contributes to lower incidence of heart‑failure related events in high‑risk patients.

What are the side effects of Olmesartan Medoxomil?

Olmesartan medoxil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea - Cough

Serious or Rare Side Effects: - Angio‑angulation  - Hyperkalemia - Acute kidney injury  - Severe hypotension  - Liver enzyme elevation  - Allergic skin reactions 

What precautions apply to Olmesartan Medoxomil?

Olmesartan medoxil should be used with careful clinical oversight, especially in patients with certain health conditions.

- Monitor blood pressure: Check regularly to ensure therapeutic targets are met. - Assess renal function: Periodic testing of serum creatinine and eGFR is recommended. - Evaluate electrolytes: Watch for potassium abnormalities, especially when combined with potassium‑sparing diuretics. - Caution in pregnancy:  - Use ". """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""

"""

"""

"""""""""""""""""""""""""

""

"""""

"

".

");

"

"

"".

"".

".

""

""

t".

"""".

"".

.

""

""".

.

"".

""

""

""

""

.

"

"".

""

""

""

""

"".

"

""

""

");

"""

""

""

""

""

"""".

""

");

"".

""

"""

""

".

".

"".

.

""

"".

"".

""

".

"

".

"" ");

""

""

""

""

");

");

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olmesartan Medoxomil
Route
Oral Use
Manufacturer
Ratiopharm-Comercio E Industria De Produtos Farmaceuticos Lda
Origin
EU

Related products